Home » Topics » BioWorld Science

BioWorld Science
RSS

XtalPi and Pfizer enter research collaboration

May 9, 2018

Alnylam achieves delivery of siRNA conjugates to CNS

May 9, 2018

Promising phase II results for TOP-1630 in dry eye syndrome

May 9, 2018

Celgene presents highlights of first quarter 2018

May 9, 2018

Biohaven establishes expanded access program for sublingual BHV-0223 for ALS

May 9, 2018

Atara Biotherapeutics expands collaboration with Memorial Sloan Kettering

May 9, 2018

Researchers present INT-1B3 as a promising antitumoral compound

May 9, 2018

Phase III TAGS trial of Lonsurf in metastatic gastric cancer meets primary endpoint

May 9, 2018

Alternative targeting of IDO pathway: New developments from the AAI annual meeting

May 9, 2018

Novo Nordisk reviews pipeline highlights of first quarter 2018

May 9, 2018

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...